Autologous Stem Cell Transfusions on Multiple Days in Patients with Multiple Myeloma - Does It Matter?
Thomas Pabst(University Hospital of Bern), Urban Novak(University of Bern), Barbara Jeker(University of Bern), Sebastian Moser(University of Bern), Ulrike Bacher(Hattiesburg Clinic), Behrouz Mansouri Taleghani(University of Bern)
Cited by 1
Related Papers
Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients
|Blood|2007|410
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
|Blood|2010|189
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
|Leukemia|2014|172